However, studies indicate that stopping semaglutide may lead to some weight gain, as the medication helps regulate appetite and metabolism
Int Urol Nephrol 1998
Weve got a lot of people, that used some form of this medication, over the last several years, and and not just for obesity, right, for diabetes in large part, and and for obesity
Figure from van der Aart-van der Beek AB, Nat Rev Nephrol, 2020 The Study Methods This was an international, event-driven, double-blind, parallel-group, randomized, placebo-controlled trial conducted at 387 sites in 28 countries comparing semaglutide to placebo in patients with T2DM and CKD, both being treated with baseline standard of care
This allows us to assess and determine the ideal treatments